✦ LIBER ✦

Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

✍ Scribed by Mihai Gheorghiade; Kirkwood F. Adams; John G.F. Cleland; Gad Cotter; G. Michael Felker; Gerasimos S. Filippatos; Gregg C. Fonarow; Barry H. Greenberg; Adrian F. Hernandez; Sadiya Khan; Michel Komajda; Marvin A. Konstam; Peter P. Liu; Aldo P. Maggioni; Barry M. Massie; John J. McMurray; Mandeep Mehra; Marco Metra; John O'Connell; Christopher M. O'Connor; Peter S. Pang; Ileana L. Piña; Hani N. Sabbah; John R. Teerlink; James E. Udelson; Clyde W. Yancy; Faiez Zannad; Norman Stockbridge

Book ID: 116191756
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 597 KB
Volume: 157
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2009.04.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End Points for Clinical Trials in Acute

End Points for Clinical Trials in Acute Heart Failure Syndromes

✍ Larry A. Allen; Adrian F. Hernandez; Christopher M. O'Connor; G. Michael Felker 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 473 KB

Usefulness of an elevated troponin-I in

Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)

✍ Wendy A Gattis; Christopher M O'Connor; Vic Hasselblad; Kirkwood F Adams Jr.; Is 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Effects of istaroxime on diastolic stiff

Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: Results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial

✍ Sanjiv J. Shah; John E.A. Blair; Gerasimos S. Filippatos; Cezar Macarie; Witold 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 232 KB